(Q42978970)

English

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

scientific article published on July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

12 November 2017

author name string

Motoko Nagano-Fujii

2

1 reference

Europe PubMed Central

12 November 2017

Noriko Sasase

3

1 reference

Europe PubMed Central

12 November 2017

Susumu Imoto

4

1 reference

Europe PubMed Central

12 November 2017

Soo-Ryang Kim

5

1 reference

Europe PubMed Central

12 November 2017

Hak Hotta

6

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 July 2008

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

48

1 reference

Europe PubMed Central

12 November 2017

38-47

1 reference

Europe PubMed Central

12 November 2017

1

1 reference

Europe PubMed Central

12 November 2017

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

21 January 2018

Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

21 January 2018

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

21 January 2018

Peginterferon and ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of hepatitis C: from empiricism to eradication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of response to therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination Therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22339

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22339

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42978970&oldid=1975615192"